Advanced Derivative Spectroscopic Method for Estimation of Montelukast and Bilastine in Their Tablet Dosage Form
Abstract
Aim of present work is development and validation of advance derivative spectroscopic method for estimation of Montelukast (MON) and Bilastine (BIL) in their tablet dosage form. This tablet dosage form is used as an anti-asthmatic and allergic rhinitis. The developed method can be applied for simultaneous estimation of Montelukast and Bilastine in their combined dosage form. For this advanced derivative method, the absorbance at 226.8 nm (ZCP of Montelukast) and 326.4 nm (ZCP of Bilastine) was used for the estimation of Montelukast and Bilastine, respectively. The developed method is validated by ICH Q2R1 guidelines with validation parameters like linearity, LOD, LOQ, accuracy, precision, robustness, ruggedness and assay were performed using this guidelines. The method was found to be linear in the concentration range of 2-14 µg/ml for Montelukast (R2=0.999) and 4-28 µg/ml for Bilastine (R2=0.9997). LOD and LOQ found 0.1216 and 0.3686 for MON and 0.3406 and 1.0320 for BIL. Precision study were carried out by comparing on 3 different concentrations and result of their %RSD were <2%. Robustness study carried out by change in scanning speed and change in methanol manufacturer and Ruggedness study carried out by different analyst. Assay study was performed using tablet formulation. The developed method was utilized for simultaneous estimation of Montelukast and Bilastine for its tablet dosage form.
Keywords:
Montelukast, Bilastine, Method validation, Advanced Derivative Spectroscopy methodDOI
https://doi.org/10.25004/IJPSDR.2021.130305References
https://cdsco.gov.in/opencms/opencms/en/Approval_new/Approved-New-Drugs/ (21 December 2020)
Martindale PK. The Complete Drug Reference. 34 ed. London, UK: The Pharmaceutical Press; 2005. 435, 788.
Scaglionte F. Safety profile of Bilastine: 2nd generation H1-antihistamines. Eur Rev Med Pharmacol Sci. 2012; 16(14): 1999- 2005.
Silva AT, Brabo GR, Marques ID, Bajerski L, Malesuik MD, Paim CS. UV Spectrophotometric method for quantitative determination of Bilastine using experimental design for robustness. Drug Analytical Research.2017; 01(2): 38-43.
Katta R, Murty N, Srinivas R and Rao GN. Stability indicating method development and validation for the determination of Bilastine and its impurities by UPLC method. International Journal of Pharmaceutical Sciences and Research. 2020; 11(3): 1312-1321.
Sharma P, Gupta SK, Kumar N, Dahiya M, Nagar P. Method Development and validation of Bilastine by HPLC. International Journal of Advanced Science and Technology. 2020; 29(7): 13751–13758.
Indian Pharmacopoeia. The Indian Pharmacopoeia Commission, Ghaziabad. Govt. of India Ministry of Health and Family Welfare. 2014; vol.III. 2247-2248.
Pallavi K and Babu PS. Validated UV spectroscopic method for estimation of Montelukast sodium from Bulk and Tablet Formulations. International journal of advances in pharmacy biology and chemistry. 2012; 1(4): 450-453.
Patel PG, Vaghela VM, Rathi SG, Rajgor NB, Bhaskar VH. Derivative spectrophotometry method for simultaneous estimation of Rupatadine and Montelukast in their Combined Dosage Form. J Young Pharm. 2009; 1(4): 354-358.
Patel NN, Rana NS, Rajesh KS, Patel PR, Limbachiya U and Pasha TY. Spectrophotometric method for simultaneous estimation of Montelukast sodium and Ebastine in Bulk and their combined tablet dosage form. Indian Journal of Pharmaceutical Education and Research. 2014; 48(2): 87-91.
Kumar SJ, Ramachandran D and Saradhi VS. RP-HPLC Method for the estimation of Montelukast sodium in pharmaceutical dosage forms. Current Trends in Biotechnology and Pharmacy. 2010; 4(4): 943-946.
Vekaria HJ, Limabasiya V and Patel P. Development and validation of RP-HPLC method for simultaneous estimation of Montelukast sodium and Fexofenadine hydrochloride in combined dosage form. Journal of Pharmacy research. 2013; 6: 134-139.
Vekaria HJ, Jat RK. Analytical method development and validation for simultaneous estimation of Acebrophylline and Montelukast sodium in their pharmaceutical dosage form. Journal of Pharmaceutical Science and Bioscientific research. 2015; 5(5): 475-480.
Vekaria HJ, Jat RK. HPTLC method for simultaneous estimation of Montelukast and Olopatadine in its combined dosage forms. International journal of Pharmaceutical sciences and research. 2015; 6(12): 5174-5178.
Ezzeldin E, Shahat A, Tammam MH. Development and validation of LC/MS/MS method for the simultaneous determination of Montelukast, Gliclazide and Nifedipine and its application to a pharmacokinetic study. Chemistry Central Journal. 2014; 8(17): 1-9.
Mohan Raj R, Shankar A. S. K., Ventrichelvan T. Analytical method development and validation for simultaneous estimation of bilastine and montelukast sodium by UV spectrophotometry. World Journal of Pharmacy and Pharmaceutical sciences. 2021;10(01):680-687.
ICH. Q2R1: Guidelines on validation of analytical procedure: Text and methodology. 2005.
Gibaldi M, Perrier D. Pharmacokinetics. New York: Marcel Dekker; 1974: 270-281.
Skoog DA, Holler FJ, Timothy A, et al. Principals of Instrumental Analysis. 5th Ed. London: Saunders College Publication; 1998:3
Swarbrick J, Boylan JC. Encyclopedia of Pharmaceutical Technology. 15th Ed. New York: Marcel Dekker; 1997:331.
Published
Abstract Display: 791 
PDF Downloads: 731 
